Selected research
Industry Research
Digital Endocrine Disease Management Industry Research Report 2026
Market perspective
The global Digital Endocrine Disease Management market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Digital Endocrine Disease Management market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Digital Endocrine Disease Management market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Digital Endocrine Disease Management market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Digital Endocrine Disease Management include Abbott Diabetes Care, Dexcom Inc, Vida Health, Welldoc, Lark Health, Roche Diabetes Care, Oviva AG, Kaia Health and CureApp Inc, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Digital Endocrine Disease Management market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Digital Endocrine Disease Management.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Digital Endocrine Disease Management Market by Company
Abbott Diabetes Care
Dexcom Inc
Vida Health
Welldoc
Lark Health
Roche Diabetes Care
Oviva AG
Kaia Health
CureApp Inc
Welby Inc
Ubie Inc
TeleMed2U
Twin Health
eddii-Care
DocVilla
Novo Nordisk Digital Health
Shangyi Technology
JD Health
Alibaba Health
Teladoc Health
Omada Health
Virta Health
Digital Endocrine Disease Management Segment by Type
Diabetes Management
Thyroid Disease Management
Obesity and Metabolic Disorder Management
PCOS Management
Osteoporosis Management
Others
Digital Endocrine Disease Management Segment by Application
Consumer Health
Chronic Disease Management
Hospital Digital Care
Employer Wellness
Others
Digital Endocrine Disease Management Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Digital Endocrine Disease Management market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Digital Endocrine Disease Management and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Digital Endocrine Disease Management.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Digital Endocrine Disease Management companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 5. Global Digital Endocrine Disease Management Market Size by Type (2021-2026) & (US$ Million)
Table 6. Global Digital Endocrine Disease Management Revenue Market Share by Type (2021-2026)
Table 7. Global Digital Endocrine Disease Management Forecasted Market Size by Type (2027-2032) & (US$ Million)
Table 8. Global Digital Endocrine Disease Management Revenue Market Share by Type (2027-2032)
Table 9. Global Digital Endocrine Disease Management Market Size by Application (2021-2026) & (US$ Million)
Table 10. Global Digital Endocrine Disease Management Revenue Market Share by Application (2021-2026)
Table 11. Global Digital Endocrine Disease Management Forecasted Market Size by Application (2027-2032) & (US$ Million)
Table 12. Global Digital Endocrine Disease Management Revenue Market Share by Application (2027-2032)
Table 13. Global Digital Endocrine Disease Management Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Table 14. Global Digital Endocrine Disease Management Market Size by Region (2021-2026) & (US$ Million)
Table 15. Global Digital Endocrine Disease Management Market Share by Region (2021-2026)
Table 16. Global Digital Endocrine Disease Management Forecasted Market Size by Region (2027-2032) & (US$ Million)
Table 17. Global Digital Endocrine Disease Management Market Share by Region (2027-2032)
Table 18. Digital Endocrine Disease Management Industry Trends
Table 19. Digital Endocrine Disease Management Industry Drivers
Table 20. Digital Endocrine Disease Management Industry Opportunities and Challenges
Table 21. Digital Endocrine Disease Management Market Restraints
Table 22. Global Top Digital Endocrine Disease Management Players by Revenue (US$ Million) & (2021-2026)
Table 23. Global Digital Endocrine Disease Management Revenue Market Share by Players (2021-2026)
Table 24. Global Digital Endocrine Disease Management Industry Players Ranking, 2024 VS 2025 VS 2026
Table 25. Global Key Players of Digital Endocrine Disease Management, Headquarters and Area Served
Table 26. Global Digital Endocrine Disease Management Players, Product Type & Application
Table 27. Global Players Market Concentration Ratio (CR5 and HHI)
Table 28. Global Digital Endocrine Disease Management by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 29. Players Mergers & Acquisitions, Expansion Plans
Table 30. North America Digital Endocrine Disease Management Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 31. North America Digital Endocrine Disease Management Market Size by Country (2021-2026) & (US$ Million)
Table 32. North America Digital Endocrine Disease Management Market Size by Country (2027-2032) & (US$ Million)
Table 33. Europe Digital Endocrine Disease Management Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 34. Europe Digital Endocrine Disease Management Market Size by Country (2021-2026) & (US$ Million)
Table 35. Europe Digital Endocrine Disease Management Market Size by Country (2027-2032) & (US$ Million)
Table 36. Asia Pacific Digital Endocrine Disease Management Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 37. Asia Pacific Digital Endocrine Disease Management Market Size by Region (2021-2026) & (US$ Million)
Table 38. Asia Pacific Digital Endocrine Disease Management Market Size by Country (2027-2032) & (US$ Million)
Table 39. South America Digital Endocrine Disease Management Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 40. South America Digital Endocrine Disease Management Market Size by Country (2021-2026) & (US$ Million)
Table 41. South America Digital Endocrine Disease Management Market Size by Country (2027-2032) & (US$ Million)
Table 42. Middle East & Africa Digital Endocrine Disease Management Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 43. Middle East & Africa Digital Endocrine Disease Management Market Size by Country (2021-2026) & (US$ Million)
Table 44. Middle East & Africa Digital Endocrine Disease Management Market Size by Country (2027-2032) & (US$ Million)
Table 45. Abbott Diabetes Care Company Information
Table 46. Abbott Diabetes Care Business Overview
Table 47. Abbott Diabetes Care Revenue in Digital Endocrine Disease Management Business (2021-2026) & (US$ Million)
Table 48. Abbott Diabetes Care Digital Endocrine Disease Management Product Portfolio
Table 49. Abbott Diabetes Care Recent Developments
Table 50. Dexcom Inc Company Information
Table 51. Dexcom Inc Business Overview
Table 52. Dexcom Inc Revenue in Digital Endocrine Disease Management Business (2021-2026) & (US$ Million)
Table 53. Dexcom Inc Digital Endocrine Disease Management Product Portfolio
Table 54. Dexcom Inc Recent Developments
Table 55. Vida Health Company Information
Table 56. Vida Health Business Overview
Table 57. Vida Health Revenue in Digital Endocrine Disease Management Business (2021-2026) & (US$ Million)
Table 58. Vida Health Digital Endocrine Disease Management Product Portfolio
Table 59. Vida Health Recent Developments
Table 60. Welldoc Company Information
Table 61. Welldoc Business Overview
Table 62. Welldoc Revenue in Digital Endocrine Disease Management Business (2021-2026) & (US$ Million)
Table 63. Welldoc Digital Endocrine Disease Management Product Portfolio
Table 64. Welldoc Recent Developments
Table 65. Lark Health Company Information
Table 66. Lark Health Business Overview
Table 67. Lark Health Revenue in Digital Endocrine Disease Management Business (2021-2026) & (US$ Million)
Table 68. Lark Health Digital Endocrine Disease Management Product Portfolio
Table 69. Lark Health Recent Developments
Table 70. Roche Diabetes Care Company Information
Table 71. Roche Diabetes Care Business Overview
Table 72. Roche Diabetes Care Revenue in Digital Endocrine Disease Management Business (2021-2026) & (US$ Million)
Table 73. Roche Diabetes Care Digital Endocrine Disease Management Product Portfolio
Table 74. Roche Diabetes Care Recent Developments
Table 75. Oviva AG Company Information
Table 76. Oviva AG Business Overview
Table 77. Oviva AG Revenue in Digital Endocrine Disease Management Business (2021-2026) & (US$ Million)
Table 78. Oviva AG Digital Endocrine Disease Management Product Portfolio
Table 79. Oviva AG Recent Developments
Table 80. Kaia Health Company Information
Table 81. Kaia Health Business Overview
Table 82. Kaia Health Revenue in Digital Endocrine Disease Management Business (2021-2026) & (US$ Million)
Table 83. Kaia Health Digital Endocrine Disease Management Product Portfolio
Table 84. Kaia Health Recent Developments
Table 85. CureApp Inc Company Information
Table 86. CureApp Inc Business Overview
Table 87. CureApp Inc Revenue in Digital Endocrine Disease Management Business (2021-2026) & (US$ Million)
Table 88. CureApp Inc Digital Endocrine Disease Management Product Portfolio
Table 89. CureApp Inc Recent Developments
Table 90. Welby Inc Company Information
Table 91. Welby Inc Business Overview
Table 92. Welby Inc Revenue in Digital Endocrine Disease Management Business (2021-2026) & (US$ Million)
Table 93. Welby Inc Digital Endocrine Disease Management Product Portfolio
Table 94. Welby Inc Recent Developments
Table 95. Ubie Inc Company Information
Table 96. Ubie Inc Business Overview
Table 97. Ubie Inc Revenue in Digital Endocrine Disease Management Business (2021-2026) & (US$ Million)
Table 98. Ubie Inc Digital Endocrine Disease Management Product Portfolio
Table 99. Ubie Inc Recent Developments
Table 100. TeleMed2U Company Information
Table 101. TeleMed2U Business Overview
Table 102. TeleMed2U Revenue in Digital Endocrine Disease Management Business (2021-2026) & (US$ Million)
Table 103. TeleMed2U Digital Endocrine Disease Management Product Portfolio
Table 104. TeleMed2U Recent Developments
Table 105. Twin Health Company Information
Table 106. Twin Health Business Overview
Table 107. Twin Health Revenue in Digital Endocrine Disease Management Business (2021-2026) & (US$ Million)
Table 108. Twin Health Digital Endocrine Disease Management Product Portfolio
Table 109. Twin Health Recent Developments
Table 110. eddii-Care Company Information
Table 111. eddii-Care Business Overview
Table 112. eddii-Care Revenue in Digital Endocrine Disease Management Business (2021-2026) & (US$ Million)
Table 113. eddii-Care Digital Endocrine Disease Management Product Portfolio
Table 114. eddii-Care Recent Developments
Table 115. DocVilla Company Information
Table 116. DocVilla Business Overview
Table 117. DocVilla Revenue in Digital Endocrine Disease Management Business (2021-2026) & (US$ Million)
Table 118. DocVilla Digital Endocrine Disease Management Product Portfolio
Table 119. DocVilla Recent Developments
Table 120. Novo Nordisk Digital Health Company Information
Table 121. Novo Nordisk Digital Health Business Overview
Table 122. Novo Nordisk Digital Health Revenue in Digital Endocrine Disease Management Business (2021-2026) & (US$ Million)
Table 123. Novo Nordisk Digital Health Digital Endocrine Disease Management Product Portfolio
Table 124. Novo Nordisk Digital Health Recent Developments
Table 125. Shangyi Technology Company Information
Table 126. Shangyi Technology Business Overview
Table 127. Shangyi Technology Revenue in Digital Endocrine Disease Management Business (2021-2026) & (US$ Million)
Table 128. Shangyi Technology Digital Endocrine Disease Management Product Portfolio
Table 129. Shangyi Technology Recent Developments
Table 130. JD Health Company Information
Table 131. JD Health Business Overview
Table 132. JD Health Revenue in Digital Endocrine Disease Management Business (2021-2026) & (US$ Million)
Table 133. JD Health Digital Endocrine Disease Management Product Portfolio
Table 134. JD Health Recent Developments
Table 135. Alibaba Health Company Information
Table 136. Alibaba Health Business Overview
Table 137. Alibaba Health Revenue in Digital Endocrine Disease Management Business (2021-2026) & (US$ Million)
Table 138. Alibaba Health Digital Endocrine Disease Management Product Portfolio
Table 139. Alibaba Health Recent Developments
Table 140. Teladoc Health Company Information
Table 141. Teladoc Health Business Overview
Table 142. Teladoc Health Revenue in Digital Endocrine Disease Management Business (2021-2026) & (US$ Million)
Table 143. Teladoc Health Digital Endocrine Disease Management Product Portfolio
Table 144. Teladoc Health Recent Developments
Table 145. Omada Health Company Information
Table 146. Omada Health Business Overview
Table 147. Omada Health Revenue in Digital Endocrine Disease Management Business (2021-2026) & (US$ Million)
Table 148. Omada Health Digital Endocrine Disease Management Product Portfolio
Table 149. Omada Health Recent Developments
Table 150. Virta Health Company Information
Table 151. Virta Health Business Overview
Table 152. Virta Health Revenue in Digital Endocrine Disease Management Business (2021-2026) & (US$ Million)
Table 153. Virta Health Digital Endocrine Disease Management Product Portfolio
Table 154. Virta Health Recent Developments
Table 155. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Digital Endocrine Disease Management Product Image
Figure 5. Global Digital Endocrine Disease Management Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 6. Global Digital Endocrine Disease Management Market Share by Type: 2025 VS 2032
Figure 7. Diabetes Management Product
Figure 8. Thyroid Disease Management Product
Figure 9. Obesity and Metabolic Disorder Management Product
Figure 10. PCOS Management Product
Figure 11. Osteoporosis Management Product
Figure 12. Others Product
Figure 13. Global Digital Endocrine Disease Management Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 14. Global Digital Endocrine Disease Management Market Share by Application: 2025 VS 2032
Figure 15. Consumer Health Product
Figure 16. Chronic Disease Management Product
Figure 17. Hospital Digital Care Product
Figure 18. Employer Wellness Product
Figure 19. Others Product
Figure 20. Global Digital Endocrine Disease Management Market Size (US$ Million), Year-over-Year: 2021-2032
Figure 21. Global Digital Endocrine Disease Management Market Size, (US$ Million), 2021 VS 2025 VS 2032
Figure 22. Global Digital Endocrine Disease Management Market Share by Region: 2025 VS 2032
Figure 23. Global Digital Endocrine Disease Management Market Share by Players in 2025
Figure 24. Global Digital Endocrine Disease Management Manufacturers Established Date
Figure 25. Global Top 5 and 10 Digital Endocrine Disease Management Players Market Share by Revenue in 2025
Figure 26. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 27. North America Digital Endocrine Disease Management Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 28. North America Digital Endocrine Disease Management Market Share by Country (2021-2032)
Figure 29. United States Digital Endocrine Disease Management Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 30. Canada Digital Endocrine Disease Management Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 31. Mexico Digital Endocrine Disease Management Market Share by Country (2021-2032)
Figure 32. Europe Digital Endocrine Disease Management Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 33. Europe Digital Endocrine Disease Management Market Share by Country (2021-2032)
Figure 34. Germany Digital Endocrine Disease Management Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 35. France Digital Endocrine Disease Management Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 36. U.K. Digital Endocrine Disease Management Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 37. Italy Digital Endocrine Disease Management Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 38. Spain Digital Endocrine Disease Management Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 39. Russia Digital Endocrine Disease Management Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 40. Netherlands Digital Endocrine Disease Management Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 41. Nordic Countries Digital Endocrine Disease Management Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 42. Asia-Pacific Digital Endocrine Disease Management Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 43. Asia-Pacific Digital Endocrine Disease Management Market Share by Country (2021-2032)
Figure 44. China Digital Endocrine Disease Management Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 45. Japan Digital Endocrine Disease Management Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 46. South Korea Digital Endocrine Disease Management Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 47. India Digital Endocrine Disease Management Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 48. India Digital Endocrine Disease Management Market Share by Country (2021-2032)
Figure 49. Australia Digital Endocrine Disease Management Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 50. China Taiwan Digital Endocrine Disease Management Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 51. Southeast Asia Digital Endocrine Disease Management Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 52. South America Digital Endocrine Disease Management Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 53. South America Digital Endocrine Disease Management Market Share by Country (2021-2032)
Figure 54. Brazil Digital Endocrine Disease Management Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 55. Argentina Digital Endocrine Disease Management Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 56. Chile Digital Endocrine Disease Management Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 57. Colombia Digital Endocrine Disease Management Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 58. Peru Digital Endocrine Disease Management Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 59. Abbott Diabetes Care Revenue Growth Rate in Digital Endocrine Disease Management Business (2021-2026)
Figure 60. Dexcom Inc Revenue Growth Rate in Digital Endocrine Disease Management Business (2021-2026)
Figure 61. Vida Health Revenue Growth Rate in Digital Endocrine Disease Management Business (2021-2026)
Figure 62. Welldoc Revenue Growth Rate in Digital Endocrine Disease Management Business (2021-2026)
Figure 63. Lark Health Revenue Growth Rate in Digital Endocrine Disease Management Business (2021-2026)
Figure 64. Roche Diabetes Care Revenue Growth Rate in Digital Endocrine Disease Management Business (2021-2026)
Figure 65. Oviva AG Revenue Growth Rate in Digital Endocrine Disease Management Business (2021-2026)
Figure 66. Kaia Health Revenue Growth Rate in Digital Endocrine Disease Management Business (2021-2026)
Figure 67. CureApp Inc Revenue Growth Rate in Digital Endocrine Disease Management Business (2021-2026)
Figure 68. Welby Inc Revenue Growth Rate in Digital Endocrine Disease Management Business (2021-2026)
Figure 69. Ubie Inc Revenue Growth Rate in Digital Endocrine Disease Management Business (2021-2026)
Figure 70. TeleMed2U Revenue Growth Rate in Digital Endocrine Disease Management Business (2021-2026)
Figure 71. Twin Health Revenue Growth Rate in Digital Endocrine Disease Management Business (2021-2026)
Figure 72. eddii-Care Revenue Growth Rate in Digital Endocrine Disease Management Business (2021-2026)
Figure 73. DocVilla Revenue Growth Rate in Digital Endocrine Disease Management Business (2021-2026)
Figure 74. Novo Nordisk Digital Health Revenue Growth Rate in Digital Endocrine Disease Management Business (2021-2026)
Figure 75. Shangyi Technology Revenue Growth Rate in Digital Endocrine Disease Management Business (2021-2026)
Figure 76. JD Health Revenue Growth Rate in Digital Endocrine Disease Management Business (2021-2026)
Figure 77. Alibaba Health Revenue Growth Rate in Digital Endocrine Disease Management Business (2021-2026)
Figure 78. Teladoc Health Revenue Growth Rate in Digital Endocrine Disease Management Business (2021-2026)
Figure 79. Omada Health Revenue Growth Rate in Digital Endocrine Disease Management Business (2021-2026)
Figure 80. Virta Health Revenue Growth Rate in Digital Endocrine Disease Management Business (2021-2026)
Scope & coverage.
Types
- Diabetes Management
- Thyroid Disease Management
- Obesity and Metabolic Disorder Management
- PCOS Management
- Osteoporosis Management
- Others
Applications
- Consumer Health
- Chronic Disease Management
- Hospital Digital Care
- Employer Wellness
- Others
Companies covered
- Abbott Diabetes Care
- Dexcom Inc
- Vida Health
- Welldoc
- Lark Health
- Roche Diabetes Care
- Oviva AG
- Kaia Health
- CureApp Inc
- Welby Inc
- Ubie Inc
- TeleMed2U
- Twin Health
- eddii-Care
- DocVilla
- Novo Nordisk Digital Health
- Shangyi Technology
- JD Health
- Alibaba Health
- Teladoc Health
- Omada Health
- Virta Health
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Digital Endocrine Disease Management by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Diabetes Management
- 2.2.3 Thyroid Disease Management
- 2.2.4 Obesity and Metabolic Disorder Management
- 2.2.5 PCOS Management
- 2.2.6 Osteoporosis Management
- 2.2.7 Others
- 2.3 Digital Endocrine Disease Management by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Consumer Health
- 2.3.3 Chronic Disease Management
- 2.3.4 Hospital Digital Care
- 2.3.5 Employer Wellness
- 2.3.6 Others
- 2.4 Assumptions and Limitations
3 Digital Endocrine Disease Management Breakdown Data by Type
- 3.1 Global Digital Endocrine Disease Management Historic Market Size by Type (2021-2026)
- 3.2 Global Digital Endocrine Disease Management Forecasted Market Size by Type (2027-2032)
4 Digital Endocrine Disease Management Breakdown Data by Application
- 4.1 Global Digital Endocrine Disease Management Historic Market Size by Application (2021-2026)
- 4.2 Global Digital Endocrine Disease Management Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Digital Endocrine Disease Management Market Perspective (2021-2032)
- 5.2 Global Digital Endocrine Disease Management Growth Trends by Region
- 5.2.1 Global Digital Endocrine Disease Management Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Digital Endocrine Disease Management Historic Market Size by Region (2021-2026)
- 5.2.3 Digital Endocrine Disease Management Forecasted Market Size by Region (2027-2032)
- 5.3 Digital Endocrine Disease Management Market Dynamics
- 5.3.1 Digital Endocrine Disease Management Industry Trends
- 5.3.2 Digital Endocrine Disease Management Market Drivers
- 5.3.3 Digital Endocrine Disease Management Market Challenges
- 5.3.4 Digital Endocrine Disease Management Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Digital Endocrine Disease Management Players by Revenue
- 6.1.1 Global Top Digital Endocrine Disease Management Players by Revenue (2021-2026)
- 6.1.2 Global Digital Endocrine Disease Management Revenue Market Share by Players (2021-2026)
- 6.2 Global Digital Endocrine Disease Management Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Digital Endocrine Disease Management Head Office and Area Served
- 6.4 Global Digital Endocrine Disease Management Players, Product Type & Application
- 6.5 Global Digital Endocrine Disease Management Manufacturers Established Date
- 6.6 Global Digital Endocrine Disease Management Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Digital Endocrine Disease Management Market Size (2021-2032)
- 7.2 North America Digital Endocrine Disease Management Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Digital Endocrine Disease Management Market Size by Country (2021-2026)
- 7.4 North America Digital Endocrine Disease Management Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Digital Endocrine Disease Management Market Size (2021-2032)
- 8.2 Europe Digital Endocrine Disease Management Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Digital Endocrine Disease Management Market Size by Country (2021-2026)
- 8.4 Europe Digital Endocrine Disease Management Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Digital Endocrine Disease Management Market Size (2021-2032)
- 9.2 Asia-Pacific Digital Endocrine Disease Management Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Digital Endocrine Disease Management Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Digital Endocrine Disease Management Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Digital Endocrine Disease Management Market Size (2021-2032)
- 10.2 South America Digital Endocrine Disease Management Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Digital Endocrine Disease Management Market Size by Country (2021-2026)
- 10.4 South America Digital Endocrine Disease Management Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Digital Endocrine Disease Management Market Size (2021-2032)
- 11.2 Middle East & Africa Digital Endocrine Disease Management Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Digital Endocrine Disease Management Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Digital Endocrine Disease Management Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Abbott Diabetes Care
- 12.1.1 Abbott Diabetes Care Company Information
- 12.1.2 Abbott Diabetes Care Business Overview
- 12.1.3 Abbott Diabetes Care Revenue in Digital Endocrine Disease Management Business (2021-2026)
- 12.1.4 Abbott Diabetes Care Digital Endocrine Disease Management Product Portfolio
- 12.1.5 Abbott Diabetes Care Recent Developments
- 12.2 Dexcom Inc
- 12.2.1 Dexcom Inc Company Information
- 12.2.2 Dexcom Inc Business Overview
- 12.2.3 Dexcom Inc Revenue in Digital Endocrine Disease Management Business (2021-2026)
- 12.2.4 Dexcom Inc Digital Endocrine Disease Management Product Portfolio
- 12.2.5 Dexcom Inc Recent Developments
- 12.3 Vida Health
- 12.3.1 Vida Health Company Information
- 12.3.2 Vida Health Business Overview
- 12.3.3 Vida Health Revenue in Digital Endocrine Disease Management Business (2021-2026)
- 12.3.4 Vida Health Digital Endocrine Disease Management Product Portfolio
- 12.3.5 Vida Health Recent Developments
- 12.4 Welldoc
- 12.4.1 Welldoc Company Information
- 12.4.2 Welldoc Business Overview
- 12.4.3 Welldoc Revenue in Digital Endocrine Disease Management Business (2021-2026)
- 12.4.4 Welldoc Digital Endocrine Disease Management Product Portfolio
- 12.4.5 Welldoc Recent Developments
- 12.5 Lark Health
- 12.5.1 Lark Health Company Information
- 12.5.2 Lark Health Business Overview
- 12.5.3 Lark Health Revenue in Digital Endocrine Disease Management Business (2021-2026)
- 12.5.4 Lark Health Digital Endocrine Disease Management Product Portfolio
- 12.5.5 Lark Health Recent Developments
- 12.6 Roche Diabetes Care
- 12.6.1 Roche Diabetes Care Company Information
- 12.6.2 Roche Diabetes Care Business Overview
- 12.6.3 Roche Diabetes Care Revenue in Digital Endocrine Disease Management Business (2021-2026)
- 12.6.4 Roche Diabetes Care Digital Endocrine Disease Management Product Portfolio
- 12.6.5 Roche Diabetes Care Recent Developments
- 12.7 Oviva AG
- 12.7.1 Oviva AG Company Information
- 12.7.2 Oviva AG Business Overview
- 12.7.3 Oviva AG Revenue in Digital Endocrine Disease Management Business (2021-2026)
- 12.7.4 Oviva AG Digital Endocrine Disease Management Product Portfolio
- 12.7.5 Oviva AG Recent Developments
- 12.8 Kaia Health
- 12.8.1 Kaia Health Company Information
- 12.8.2 Kaia Health Business Overview
- 12.8.3 Kaia Health Revenue in Digital Endocrine Disease Management Business (2021-2026)
- 12.8.4 Kaia Health Digital Endocrine Disease Management Product Portfolio
- 12.8.5 Kaia Health Recent Developments
- 12.9 CureApp Inc
- 12.9.1 CureApp Inc Company Information
- 12.9.2 CureApp Inc Business Overview
- 12.9.3 CureApp Inc Revenue in Digital Endocrine Disease Management Business (2021-2026)
- 12.9.4 CureApp Inc Digital Endocrine Disease Management Product Portfolio
- 12.9.5 CureApp Inc Recent Developments
- 12.10 Welby Inc
- 12.10.1 Welby Inc Company Information
- 12.10.2 Welby Inc Business Overview
- 12.10.3 Welby Inc Revenue in Digital Endocrine Disease Management Business (2021-2026)
- 12.10.4 Welby Inc Digital Endocrine Disease Management Product Portfolio
- 12.10.5 Welby Inc Recent Developments
- 12.11 Ubie Inc
- 12.11.1 Ubie Inc Company Information
- 12.11.2 Ubie Inc Business Overview
- 12.11.3 Ubie Inc Revenue in Digital Endocrine Disease Management Business (2021-2026)
- 12.11.4 Ubie Inc Digital Endocrine Disease Management Product Portfolio
- 12.11.5 Ubie Inc Recent Developments
- 12.12 TeleMed2U
- 12.12.1 TeleMed2U Company Information
- 12.12.2 TeleMed2U Business Overview
- 12.12.3 TeleMed2U Revenue in Digital Endocrine Disease Management Business (2021-2026)
- 12.12.4 TeleMed2U Digital Endocrine Disease Management Product Portfolio
- 12.12.5 TeleMed2U Recent Developments
- 12.13 Twin Health
- 12.13.1 Twin Health Company Information
- 12.13.2 Twin Health Business Overview
- 12.13.3 Twin Health Revenue in Digital Endocrine Disease Management Business (2021-2026)
- 12.13.4 Twin Health Digital Endocrine Disease Management Product Portfolio
- 12.13.5 Twin Health Recent Developments
- 12.14 eddii-Care
- 12.14.1 eddii-Care Company Information
- 12.14.2 eddii-Care Business Overview
- 12.14.3 eddii-Care Revenue in Digital Endocrine Disease Management Business (2021-2026)
- 12.14.4 eddii-Care Digital Endocrine Disease Management Product Portfolio
- 12.14.5 eddii-Care Recent Developments
- 12.15 DocVilla
- 12.15.1 DocVilla Company Information
- 12.15.2 DocVilla Business Overview
- 12.15.3 DocVilla Revenue in Digital Endocrine Disease Management Business (2021-2026)
- 12.15.4 DocVilla Digital Endocrine Disease Management Product Portfolio
- 12.15.5 DocVilla Recent Developments
- 12.16 Novo Nordisk Digital Health
- 12.16.1 Novo Nordisk Digital Health Company Information
- 12.16.2 Novo Nordisk Digital Health Business Overview
- 12.16.3 Novo Nordisk Digital Health Revenue in Digital Endocrine Disease Management Business (2021-2026)
- 12.16.4 Novo Nordisk Digital Health Digital Endocrine Disease Management Product Portfolio
- 12.16.5 Novo Nordisk Digital Health Recent Developments
- 12.17 Shangyi Technology
- 12.17.1 Shangyi Technology Company Information
- 12.17.2 Shangyi Technology Business Overview
- 12.17.3 Shangyi Technology Revenue in Digital Endocrine Disease Management Business (2021-2026)
- 12.17.4 Shangyi Technology Digital Endocrine Disease Management Product Portfolio
- 12.17.5 Shangyi Technology Recent Developments
- 12.18 JD Health
- 12.18.1 JD Health Company Information
- 12.18.2 JD Health Business Overview
- 12.18.3 JD Health Revenue in Digital Endocrine Disease Management Business (2021-2026)
- 12.18.4 JD Health Digital Endocrine Disease Management Product Portfolio
- 12.18.5 JD Health Recent Developments
- 12.19 Alibaba Health
- 12.19.1 Alibaba Health Company Information
- 12.19.2 Alibaba Health Business Overview
- 12.19.3 Alibaba Health Revenue in Digital Endocrine Disease Management Business (2021-2026)
- 12.19.4 Alibaba Health Digital Endocrine Disease Management Product Portfolio
- 12.19.5 Alibaba Health Recent Developments
- 12.20 Teladoc Health
- 12.20.1 Teladoc Health Company Information
- 12.20.2 Teladoc Health Business Overview
- 12.20.3 Teladoc Health Revenue in Digital Endocrine Disease Management Business (2021-2026)
- 12.20.4 Teladoc Health Digital Endocrine Disease Management Product Portfolio
- 12.20.5 Teladoc Health Recent Developments
- 12.21 Omada Health
- 12.21.1 Omada Health Company Information
- 12.21.2 Omada Health Business Overview
- 12.21.3 Omada Health Revenue in Digital Endocrine Disease Management Business (2021-2026)
- 12.21.4 Omada Health Digital Endocrine Disease Management Product Portfolio
- 12.21.5 Omada Health Recent Developments
- 12.22 Virta Health
- 12.22.1 Virta Health Company Information
- 12.22.2 Virta Health Business Overview
- 12.22.3 Virta Health Revenue in Digital Endocrine Disease Management Business (2021-2026)
- 12.22.4 Virta Health Digital Endocrine Disease Management Product Portfolio
- 12.22.5 Virta Health Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$2,950USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst